Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03879018 · ClinicalTrials.gov registry record · NA
Retraining Reaching in Cerebellar Ataxia
A NA study of Cerebellar Ataxia, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- Recruiting
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT03879018: Recruiting NA study of Cerebellar Ataxia, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
NCT03879018 is a NA study of Cerebellar Ataxia that is actively recruiting participants, run by Hugo W. Moser Research Institute at Kennedy Krieger. The registered enrollment target is 18 participants, below the 347-participant average among 5 other Cerebellar Ataxia trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03879018, a NA study of Cerebellar Ataxia, is actively recruiting participants, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- RECRUITING
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test for benefits of reinforcement based training paradigm versus standard practice over weeks for improving reaching movements in people with ataxia.
Primary Outcome
Hand path distance is the percent above an ideal (straight reach) averaged over reaches to all 4 targets. To collect this measure, investigators will use motion capture equipment to record the positions of active markers that subjects will wear on their shoulder, elbow, wrist, and finger.
Conditions Studied
Interventions
- BEHAVIORAL Reach training with visual feedback
Study Locations (1)
Maryland
- Motion Analysis Lab in the Kennedy Krieger Institute - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2026-05-01 |
| Phase | NA |
What NCT03879018 shows while recruiting
NCT03879018 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 347-participant average among 5 other Cerebellar Ataxia trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Cerebellar Ataxia appearing as the primary indexed condition, and to 1 intervention - of which Reach training with visual feedback is the first listed.
NCT03879018 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT03879018 about?
NCT03879018 is a clinical study titled "Retraining Reaching in Cerebellar Ataxia". The purpose of this study is to test for benefits of reinforcement based training paradigm versus standard practice over weeks for improving reaching movements in people with ataxia.
What is the current status of trial NCT03879018?
This trial is currently recruiting. It is a NA study. The enrollment target is 18 participants. The study started on 2019-08-01. Estimated completion is 2026-05-01.
What conditions does trial NCT03879018 study?
This clinical trial studies the following conditions: Cerebellar Ataxia.
What interventions are being tested in trial NCT03879018?
The interventions under investigation include: Reach training with visual feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT03879018?
This trial is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03879018 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cerebellar Ataxia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Home Exercise for Individuals with Neurodegenerative Disease
RECRUITING · NA
-
Motor Learning After Cerebellar Damage: The Role of the Primary Motor Cortex
ACTIVE NOT RECRUITING · NA
-
The Role of Cerebellum in Speech
ACTIVE NOT RECRUITING · NA
-
Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases
RECRUITING
-
Promoting Physical Activity Engagement for People With Early-stage Cerebellar Ataxia
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI